Table 1: Clinical characteristics and
laboratory parameters of the patients.
|
|
Number of
patients (n/%) |
|
Gender
(Female/Male) |
18
(40 %)/27 (60 %) |
|
Acute
lymphoblastic leukemia |
35
(77%) |
|
Non-Hodgkin
Lymphoma |
5
(11%) |
|
Aplastic
anemia |
2(5%) |
|
HLH |
2
(5%) |
|
Neuroblastoma |
1(2%) |
|
Total |
45
(100%) |
|
|
Median (Q1-Q3) |
|
Age
(years) |
8.25
(3.5-13) |
|
Haemoglobin
(g/dl) |
8.8(7.9-9.6) |
|
Leukocyte
count (/mm3) |
700(377.5-1600) |
|
Absolute
neutrophil count (/mm3) |
100(0-412.5) |
|
Platelet
count(/mm3) |
39000
(22500-69750) |
|
CRP
(mg/dl) |
10.8(5.2-19.5) |
|
Procalcitonin
(ng/ml) |
0.5
(0.2-3.7) |
|
pRIFLE criteria |
Number of febrile
neutropenia attacks (n/%) |
|
Risk |
7
(11%) |
|
Injury |
8
(13%) |
|
Failure |
1
(2%) |
|
Total |
16
(26%) |
|
Hypokalemia |
Number of febrile
neutropenia attacks (n/%) |
|
Mild |
15
(24%) |
|
Moderate |
9
(15%) |
|
Severe |
2
(3%) |
|
Total |
26
(42%) |
CRP:
C-reactive protein; HLH: Hemophagocytic lymphohistiocytosis.